Bill Schmidt, Managing Partner of Cultivation Capital’s Life Science Fund, is optimistic about the future of Life Science investment in St. Louis. He said, “More capital is flowing in St. Louis, with us, BioGenerator, RiverVest Venture Partners, Lewis & Clark Ventures, Ascension Ventures, iSelect Fund, St. Louis Arch Angels, Missouri Technology Corporation, and others. And, we are starting to get attention from upmarket VC firms on the coasts, which is great, as our companies are going to need it.”
Cultivation Capital’s Life Sciences fund invests in early-stage companies, primarily in the therapeutics, diagnostics, research tools and reagents, medical devices, and healthcare information technology verticals.
